PRQR – ProQR Therapeutics N.V.
PRQR — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
2.38
Margin Of Safety %
Put/Call OI Ratio
0.01
EPS Next Q Diff
-0.06
EPS Last/This Y
-0.1
EPS This/Next Y
-0.14
Price
1.7
Target Price
9.03
Analyst Recom
1
Performance Q
-16.67
Upside
-444.1%
Beta
0.13
Ticker: PRQR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | PRQR | 1.9 | 0.01 | 0.00 | 3390 |
| 2026-03-10 | PRQR | 1.79 | 0.01 | 0.00 | 3390 |
| 2026-03-11 | PRQR | 1.82 | 0.01 | 0.00 | 3390 |
| 2026-03-12 | PRQR | 1.72 | 0.01 | 0.00 | 3390 |
| 2026-03-13 | PRQR | 1.72 | 0.01 | 0.00 | 3390 |
| 2026-03-17 | PRQR | 1.77 | 0.01 | 0.00 | 3392 |
| 2026-03-18 | PRQR | 1.71 | 0.01 | 0.00 | 3396 |
| 2026-03-19 | PRQR | 1.59 | 0.01 | 0.00 | 4244 |
| 2026-03-20 | PRQR | 1.54 | 0.01 | 0.00 | 4244 |
| 2026-03-23 | PRQR | 1.54 | 0.01 | 0.00 | 4244 |
| 2026-03-24 | PRQR | 1.485 | 0.01 | 0.00 | 4244 |
| 2026-03-25 | PRQR | 1.57 | 0.01 | 0.00 | 3772 |
| 2026-03-26 | PRQR | 1.51 | 0.01 | 0.00 | 3772 |
| 2026-03-27 | PRQR | 1.37 | 0.01 | 0.00 | 3772 |
| 2026-03-30 | PRQR | 1.5 | 0.01 | 0.07 | 3778 |
| 2026-03-31 | PRQR | 1.62 | 0.01 | 0.00 | 3799 |
| 2026-04-01 | PRQR | 1.7 | 0.01 | 0.07 | 3764 |
| 2026-04-02 | PRQR | 1.71 | 0.01 | 0.00 | 4047 |
| 2026-04-06 | PRQR | 1.81 | 0.01 | 0.00 | 4017 |
| 2026-04-07 | PRQR | 1.71 | 0.01 | 0.00 | 4103 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | PRQR | 1.90 | - | - | -0.48 |
| 2026-03-10 | PRQR | 1.79 | - | - | -0.48 |
| 2026-03-11 | PRQR | 1.81 | - | - | -0.48 |
| 2026-03-12 | PRQR | 1.73 | - | - | -0.48 |
| 2026-03-13 | PRQR | 1.82 | - | - | -0.48 |
| 2026-03-17 | PRQR | 1.77 | - | - | -0.62 |
| 2026-03-18 | PRQR | 1.71 | - | - | -0.62 |
| 2026-03-19 | PRQR | 1.59 | - | - | -0.62 |
| 2026-03-20 | PRQR | 1.54 | - | - | -0.56 |
| 2026-03-23 | PRQR | 1.54 | - | - | -0.56 |
| 2026-03-24 | PRQR | 1.48 | - | - | -0.56 |
| 2026-03-25 | PRQR | 1.58 | - | - | -0.56 |
| 2026-03-26 | PRQR | 1.50 | - | - | -0.56 |
| 2026-03-27 | PRQR | 1.38 | - | - | -0.56 |
| 2026-03-30 | PRQR | 1.51 | - | - | -0.56 |
| 2026-03-31 | PRQR | 1.63 | - | - | -0.56 |
| 2026-04-01 | PRQR | 1.72 | - | - | -0.56 |
| 2026-04-02 | PRQR | 1.70 | - | - | -0.56 |
| 2026-04-06 | PRQR | 1.81 | - | - | -0.56 |
| 2026-04-07 | PRQR | 1.70 | - | - | -0.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | PRQR | 0.00 | -0.39 | 2.52 |
| 2026-03-10 | PRQR | 0.00 | -0.39 | 2.52 |
| 2026-03-11 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-12 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-13 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-17 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-18 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-19 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-20 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-23 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-24 | PRQR | 0.00 | -0.39 | 2.41 |
| 2026-03-25 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-03-26 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-03-27 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-03-30 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-03-31 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-04-01 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-04-02 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-04-06 | PRQR | 0.00 | -0.39 | 2.38 |
| 2026-04-07 | PRQR | 0.00 | -0.39 | 2.38 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.09
Avg. EPS Est. Current Quarter
-0.14
Avg. EPS Est. Next Quarter
-0.15
Insider Transactions
Institutional Transactions
-0.39
Beta
0.13
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
5
Fair Value
Quality Score
24
Growth Score
23
Sentiment Score
95
Actual DrawDown %
81.3
Max Drawdown 5-Year %
-93.4
Target Price
9.03
P/E
Forward P/E
PEG
P/S
10
P/B
3.02
P/Free Cash Flow
EPS
-0.45
Average EPS Est. Cur. Y
-0.56
EPS Next Y. (Est.)
-0.7
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-266.13
Relative Volume
1.49
Return on Equity vs Sector %
-112.9
Return on Equity vs Industry %
-96.4
EPS 1 7Days Diff
0.1
EPS 1 30Days Diff
0.06
EBIT Estimation
◆
PRQR
Healthcare
$1.70
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
53.2
Range 1M
54.6%
Sup Dist
0.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-28.6%
EPS NY
-18.8%
52W%
30.1%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+431.2% upside
Upside
+431.2%
Quality
24
ProQR Therapeutics N.V.Sector: Healthcare
Industry: Biotechnology
Employees: 186
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
PRQR
Latest News
—
Caricamento notizie per PRQR…
stock quote shares PRQR – ProQR Therapeutics N.V. Stock Price stock today
news today PRQR – ProQR Therapeutics N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch PRQR – ProQR Therapeutics N.V. yahoo finance google finance
stock history PRQR – ProQR Therapeutics N.V. invest stock market
stock prices PRQR premarket after hours
ticker PRQR fair value insiders trading